Rhabdomyolysis in prostate cancer - Caution in prescribing cyproterone acetate with statins

被引：2

作者：

Ahamed, E ^{[1
]}

Bissett, D ^{[1
]}

机构：

[1] Grampian Univ Hosp NHS Trust, Dept Clin Oncol, Aberdeen, Scotland

来源：

CLINICAL ONCOLOGY | 2004年 / 16卷 / 08期

关键词：

cyproterone acetate; prostate cancer; steroids;

D O I：

10.1016/j.clon.2004.05.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

收藏

页码：528 / 529

页数：2

相关论文

共 4 条

[1] The role of antiandrogen monotherapy in the treatment of prostate cancer
Anderson, J
[J]. BJU INTERNATIONAL, 2003, 91 (05) : 455 - 461
[2] Dalesio O, 2000, LANCET, V355, P1491
[3] Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole
Neuvonen, PJ
Kantola, T
Kivistö, KT
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (03) : 332 - 341
[4] Statin-associated myopathy
Thompson, PD
Clarkson, P
Karas, RH
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (13): : 1681 - 1690